If new medicines for treatment of severe malaria become necessary because of the widespread failure of artemisinins it is likely that either i.v. quinine will be reinstigated or the subset of TCP-1 molecules, already shown to be effective in uncomplicated malaria and for which an intravenous formulation is feasible, will be investigated. Here, TCP1 is linked to malaria.